journal article·2022-02-12Open access

Computational Evaluation of Cardiac Function in Children Supported with Heartware VAD, HeartMate 2 and HeartMate 3 Left Ventricular Assist Devices

Koray K. Şafak, Mehmet Can Aluç, Selim Bozkurt

Applied Sciences· Volume 12· Issue 4

Abstract

Heart failure is one of the principal causes of morbidity and mortality in children. Treatment techniques may not work, and heart transplantation may be required as a result. The current state of donor-organ supply means that many patients cannot undergo transplantation. In these patients, ventricular assist devices (VADs) may be used to bridge the time until the transplantation. Continuous-flow VADs are increasingly being implanted to paediatric patients. The aim of this study was to evaluate cardiac function in children supported with Heartware HVAD, HeartMate2 and HeartMate3 devices using computational simulations. A lumped-parameter model simulating cardiac function in children around 12 years of age was used to simulate dilated cardiomyopathy and heart-pump support. The operating speeds in HVAD, HeartMate2 and HeartMate3 were selected as 2600 rpm, 8700 rpm and 5200 rpm constant speed, respectively, while the Lavare cycle and artificial-pulse modes were used to generate mean pump outputs at around 4.40 L/min and mean arterial pressures at around 82 mmHg in each device. Aortic pulse pressure was 11 mmHg, 14 mmHg and 6 mmHg under HVAD, HeartMate2 and HeartMate3 support, respectively. HVAD’s Lavare cycle and HeartMate3’s artificial pulse increased aortic pulse pressure to 15 mmHg and 20 mmHg. HeartMate3 with artificial-pulse mode may be more beneficial in reducing arterial-pulsatility-associated problems.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Mechanical Circulatory Support Devices · Cardiac Structural Anomalies and Repair · Fuel Cells and Related Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Mechanical Engineering, Yeditepe University, Istanbul 34755, Turkey

School of Engineering, Ulster University, Newtownabbey BT37 0QB, UK

References (37)

Show source-provided references
1. Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association10.1161/CIR.0000000000000682 ↗
2. Systematic Literature Review on the Incidence and Prevalence of Heart Failure in Children and Adolescents10.1007/s00246-017-1787-2 ↗
3. George, A.N., Hsia, T.-Y., Schievano, S., and Bozkurt, S. (2021). Complications in Children with Ventricular Assist Devices: Systematic Review and Meta-Analyses. Heart Fail Rev.10.1007/s10741-021-10093-x ↗
4. The Highest Mortality Rates in Childhood Dilated Cardiomyopathy Occur during the First Year after Diagnosis10.1111/apa.14183 ↗
5. Dilated Cardiomyopathy in Children10.1016/j.paed.2012.08.009 ↗
6. Current Management of Pediatric Dilated Cardiomyopathy10.1097/HCO.0b013e328335b220 ↗
7. Pediatric Ventricular Assist Devices
8. Mechanical Circulatory Support Challenges in Pediatric and (Adult) Congenital Heart Disease10.1097/MOT.0000000000000522 ↗
9. Early Experience with the HeartMate 3 Continuous-Flow Ventricular Assist Device in Pediatric Patients and Patients with Congenital Heart Disease: A Multicenter Registry Analysis10.1016/j.healun.2020.02.007 ↗
10. Pediatric Ventricular Assist Devices: Bridge to a New Era of Perioperative Care10.1111/pan.13609 ↗
11. Pediatric Ventricular Assist Devices: Current Challenges and Future Prospects10.2147/VHRM.S82379 ↗
12. Outcomes of Pediatric Patients Supported by the HeartMate II Left Ventricular Assist Device in the United States10.1016/j.healun.2013.07.012 ↗
13. HeartWare HVAD for Biventricular Support in Children and Adolescents: The Stanford Experience10.1097/MAT.0000000000000356 ↗
14. Fluid Dynamics in the HeartMate 3: Influence of the Artificial Pulse Feature and Residual Cardiac Pulsation10.1111/aor.13346 ↗
15. Bozkurt, S. (2019). Mathematical Modeling of Cardiac Function to Evaluate Clinical Cases in Adults and Children. PLoS ONE, 14.10.1371/journal.pone.0224663 ↗
16. Total Burn Surface Area (TBSA): Propose of a New Objective Approach Based on the Body Mass Index (BMI)10.1016/j.burns.2010.04.016 ↗
17. Estimation of Body Surface Area in Various Childhood Ages–Validation of the Mosteller Formula10.1111/j.1651-2227.2011.02580.x ↗
18. Hydraulic Characterization of Implantable Rotary Blood Pumps10.1109/TBME.2018.2876840 ↗
19. Continuous Flow Device Support in Children Using the HeartWare HVAD: 1,000 Days of Lessons Learned From a Single Center Experience10.1097/MAT.0000000000000253 ↗
20. Successful Use of the Heart Ware HVAD as Bridge to Transplantation in an 8year Old Boy with a Previous History of Berlin Heart EXCOR Support
21. Japanese Multicenter Outcomes With the HeartMate II Left Ventricular Assist Device in Patients With Small Body Surface Area10.1253/circj.CJ-16-0203 ↗
22. Morales, D. (2019). HeartMate 3TM Implant in Pediatric Patient with Dilated Cardiomyopathy. CTS Net.
23. Implantation of a HeartMate 3 in a 13-Year-Old Child with Dilated Cardiomyopathy10.1007/s00246-019-02229-6 ↗
24. The Lavare Cycle: A Novel Pulsatile Feature of the HVAD Continuous-Flow Left Ventricular Assist Device10.1053/j.jvca.2018.11.029 ↗
25. The Unique Blood Pressures and Pulsatility of LVAD Patients: Current Challenges and Future Opportunities10.1007/s11906-017-0782-6 ↗
26. Continuous-Flow Rotary Left Ventricular Assist Devices with “3rd Generation” Design10.1053/j.semtcvs.2008.08.002 ↗
27. Left Ventricular Assist Devices: From the Bench to the Clinic
28. Endothelial Function in Patients with Continuous-Flow Left Ventricular Assist Devices10.1177/0003319720946977 ↗
29. Attenuation in Peripheral Endothelial Function after Continuous Flow Left Ventricular Assist Device Therapy Is Associated with Cardiovascular Adverse Events10.1253/circj.CJ-14-1079 ↗
30. A Fully Magnetically Levitated Left Ventricular Assist Device–Final Report10.1056/NEJMoa1900486 ↗
31. Dealing with Surgical Left Ventricular Assist Device Complications
32. Heart Failure in the Young: Insights into Myocardial Recovery with Ventricular Assist Device Support10.21037/cdt-20-278 ↗
33. Klabunde, R. (2011). Cardiovascular Physiology Concepts, LWW. [2nd ed.].
34. Interaction between Carotid Baroregulation and the Pulsating Heart: A Mathematical Model
35. Evaluating the Hemodynamical Response of a Cardiovascular System under Support of a Continuous Flow Left Ventricular Assist Device via Numerical Modeling and Simulations10.1155/2013/986430 ↗
36. FDA (2021). Medtronic Stops Distribution and Sale of HeartWare HVAD System Due to Risk of Neurological Adverse Events, Mortality, and Potential Failure to Restart, FDA.
37. Application of a Lumped Parameter Model to Study the Feasibility of Simultaneous Implantation of a Continuous Flow Ventricular Assist Device (VAD) and a Pulsatile Flow VAD in BIVAD Patients10.1111/aor.12911 ↗